Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 41: 1518-1521, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petrarulo, M.
Right arrow Articles by Linari, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petrarulo, M.
Right arrow Articles by Linari, F.

Clinical Chemistry, Vol 41, 1518-1521, Copyright © 1995 by American Association for Clinical Chemistry

Citrate in urine determined with a new citrate lyase method

M Petrarulo, P Facchini, E Cerelli, M Marangella and F Linari
Renal Stone Laboratory, Mauriziano Umberto I Hospital, Turin, Italy.

An enzyme-spectrophotometric method to determine citrate in biological fluids is proposed, based on citrate lyase-catalyzed and phenylhydrazine reactions. The enzyme converts citrate into oxaloacetate, which, in the presence of phenylhydrazine, is transformed into the corresponding phenylhydrazone. The ultraviolet-absorbing product is determined by absorbance measurement at 330 nm. The method is more precise and twice as sensitive as the traditional citrate lyase method and, because it does not require the use of additional enzymes and coenzymes, is cheaper and simpler. Mean analytical recovery of citrate averaged 100.7% +/- 2.2%, imprecision (CV) of the assay for citrate at 0.96 mmol/L (urine) was 2.0%, and the lower limit of quantification was 0.08 mmol/L. Results correlated well with those by both ion-chromatographic and traditional citrate lyase methods.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Nutr.Home page
L. K. Massey, M. Liebman, and S. A. Kynast-Gales
Ascorbate Increases Human Oxaluria and Kidney Stone Risk
J. Nutr., July 1, 2005; 135(7): 1673 - 1677.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
M. E Mycielska, C. P Palmer, W. J Brackenbury, and M. B. A Djamgoz
Expression of Na+-dependent citrate transport in a strongly metastatic human prostate cancer PC-3M cell line: regulation by voltage-gated Na+ channel activity
J. Physiol., March 1, 2005; 563(2): 393 - 408.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
M. E. Mycielska and M. B. A. Djamgoz
Citrate transport in the human prostate epithelial PNT2-C2 cell line: electrophysiological analyses
J. Physiol., September 15, 2004; 559(3): 821 - 833.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.